Panel Punts On PET For Initial Diagnosis Of Cancer In Dense-Breasted Women
This article was originally published in The Gray Sheet
Public input prior to the formulation of questions for a technology assessment potentially could have allowed a more thorough evaluation of PET scanning in the initial diagnosis of cancer in dense-breasted women by the Medicare Coverage Advisory Committee's Diagnostic Imaging Panel June 19
You may also be interested in...
The Centers for Medicare & Medicaid Services is inviting interested parties to submit a separate coverage request for FDG-PET in women who have dense breast tissue
The first trial of the new Flash ultra-high dose radiation therapy with Varian Medical Systems’ ProBeam particle accelerator has begun. Agum Sharda, Varian’s senior director of Flash, says the technology could be a major advance for cancer patients.